OUR

PORTFOLIO

The Verity Pharmaceuticals portfolio focuses on clinically relevant, in-demand prescription therapeutics for the benefit of healthcare providers and their patients across a range of therapeutic areas including Urology, Oncology, Infectious Disease, and Men’s and Women’s Health.

 

Brands

 

TRELSTAR

Trelstar® is a gonadotropin-releasing hormone (GnRH) agonist approved for use in the United States for patients with prostate cancer.

Trelstar® Prescribing Information

To learn more about Trelstar® or to order Trelstar® visit www.trelstar.com

Trelstar Packaging

 

 

Sancuso

Sancuso® is the first and only FDA-approved prescription patch for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment.

Sancuso® Prescribing Information

To learn more about Sancuso® or to order Sancuso® visit www.sancuso.com

Sancuso patch

 

 

 

Partnered Brands in Puerto Rico

 

Akynzeo

Akynzeo® is the first and only 5-HT3 and NK1 receptor antagonists fixed combination approved for the prevention of chemotherapy-induced acute and delayed nausea and vomiting.

Akynzeo Prescribing Information

To learn more about Akynzeo® visit www.helsinn.com

Annovera

Annovera® is a combined hormonal contraceptive vaginal ring that can be used for an entire year.

Annovera Prescribing Information

To learn more about Annovera® visit www.annovera.com

Bijuva

Bijuva® is the first and only FDA-approved combination of bio-identical estradiol and bio-identical progesterone in a single daily oral capsule.

Bijuva Prescribing Information

To learn more about Bijuva® visit www.bijuva.com

Imvexxy

Imvexxy® is a softgel vaginal insert used to treat moderate to severe painful sex, a symptom of vulvar and vaginal atrophy (VVA), after menopause.

Imvexxy Prescribing Information

To learn more about Imvexxy® visit www.imvexxy.com

natesto

Natesto® is a nasal testosterone replacement therapy used for the treatment of male hypogonadism.

Natesto Prescribing Information

To learn more about Natesto® visit www.natesto.com

Valchlor

Valchlor® is an alkylating drug indicated for the topical treatment of Stage IA and IB mycosis fungoides‐type cutaneous T‐cell lymphoma in patients who have received prior skin‐directed therapy.

Valchlor Prescribing Information

To learn more about Valchlor® visit www.valchlor.com

vibativ

Vibativ® (telavancin) is an FDA-approved injectable antibiotic used in the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.

Vibativ Prescribing Information

To learn more about Vibativ® visit www.vibativ.com

 

 

Learn more about our product pipeline

 

Our Pipeline